gland pharma glp-1 manufacturing capacity India's pharmaceutical industry is witnessing another massive strategic move ๐๐ Anupam Rasayan plans to acquire up to 43% stake in Bliss GVS in a โน1,369 crore deal, signaling stronger expansion, integrated Battle of GLP-1 delivery technologies
Pay in 4 interest-free payments of $6.22 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours ยท Estimated delivery Aug 1 - Aug 6
























